Sorting Nexin 31 (SNX31) is part of the sorting nexin family, which plays a critical role in intracellular trafficking, endocytosis, and cell signaling. These proteins are characterized by their Phox-homology (PX) domain that binds phosphoinositides, essential for targeting to membrane surfaces. SNX31, like its family members, is implicated in the regulation of vesicular transport and may influence the sorting of proteins to various cellular compartments.Though less characterized than other sorting nexins, SNX31 is thought to participate in the dynamic remodeling of cellular membranes, a process integral to maintaining cellular homeostasis and responding to environmental cues. Its activity is likely crucial for the proper functioning of endosomes, which are central hubs in the endocytic pathway, sorting internalized molecules and recycling them back to the plasma membrane or sending them to lysosomes for degradation.
The precise biological functions of SNX31 remain to be fully elucidated. However, the study of SNX31 and related proteins is essential as it can shed light on the fundamental processes of cellular organization and the pathology of diseases where trafficking is disrupted, such as neurodegenerative disorders and cancer. Understanding SNX31's role could lead to new insights into the molecular mechanisms underpinning these conditions and might provide novel targets. As research progresses, the picture of SNX31's involvement in cellular trafficking will become clearer, providing a deeper understanding of its functions and regulatory mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As a diacylglycerol analog, PMA activates protein kinase C, which could influence signaling pathways affecting SNX31 expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An activator of adenylate cyclase, forskolin increases cAMP levels, potentially affecting SNX31 gene regulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Affects glycogen synthase kinase-3 (GSK-3) activity, which could alter signaling pathways and possibly SNX31 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, rapamycin can affect autophagy and protein sorting, potentially influencing SNX31 levels. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
An inhibitor of the V-ATPase proton pump, affecting endosomal acidification and potentially SNX31 expression. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
A cholesterol transport inhibitor that can disrupt endosomal sorting and potentially affect SNX31 expression. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts lysosomal sorting, which might influence the expression of sorting nexins. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
By inhibiting lysosomal function, chloroquine could affect cellular trafficking pathways and SNX31 expression. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
May induce stress responses that alter the regulation of proteins involved in cellular trafficking, including SNX31. | ||||||